Your browser doesn't support javascript.
loading
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.
Gotfrit, Joanna; Goodwin, Rachel; Asmis, Timothy; Hyde, Angela J; Alcindor, Thierry; Aubin, Francine; Berry, Scott; Bossé, Dominick; Brown, Colin; Burkes, Ronald; Burnell, Margot; Colwell, Bruce; Corbett, Jessica; Craswell, Jeff; Daaboul, Nathalie; Doherty, Mark; Fleming, D A Barry; Galvis, Luisa; Goel, Rakesh; Harb, Mohammed; Jeyakumar, Alwin; Jonker, Derek; Kennedy, Erin; Lock, Michael; Mahmud, Aamer; McCrea, Patrick H; Nair, Vimoj; Nassabein, Rami; Nessim, Carolyn; Ramjeesingh, Ravi; Raza, Muhammad; Saliba, Wissam; Samimi, Satareh; Singh, Simron; Snow, Stephanie; Tehfé, Mustapha; Thirlwell, Michael; Valdes, Mario; Welch, Stephen; Vickers, Michael.
Afiliación
  • Gotfrit J; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Goodwin R; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Asmis T; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Hyde AJ; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Alcindor T; McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Aubin F; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 3E4, Canada.
  • Berry S; Department of Oncology, Cancer Centre of Southeastern Ontario, Queen's University, Kingston, ON K7L 5P9, Canada.
  • Bossé D; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Brown C; PEI Cancer Treatment Centre, Charlottetown, PE C1A 8T5, Canada.
  • Burkes R; Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
  • Burnell M; Saint John Regional Hospital, Saint John, NB E2L 4L2, Canada.
  • Colwell B; Queen Elizabeth II Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
  • Corbett J; PEI Cancer Treatment Centre, Charlottetown, PE C1A 8T5, Canada.
  • Craswell J; Health PEI, Charlottetown, PE C1A 6A5, Canada.
  • Daaboul N; Centre Intégré de Cancérologie de la Montérégie, Hôpital Charles LeMoyne, Longueuil, QC J4V 2G9, Canada.
  • Doherty M; Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada.
  • Fleming DAB; Department of Surgery, Memorial University, St. John's, NL A1C 5S7, Canada.
  • Galvis L; Dr Everett Chalmers Regional Hospital, Fredericton, NB E3B 5N5, Canada.
  • Goel R; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Harb M; The Moncton City Hospital, Moncton, NB E1C 6Z8, Canada.
  • Jeyakumar A; Queen Elizabeth II Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
  • Jonker D; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Kennedy E; Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
  • Lock M; London Regional Cancer Program, London, ON N6A 5W9, Canada.
  • Mahmud A; Department of Oncology, Cancer Centre of Southeastern Ontario, Queen's University, Kingston, ON K7L 5P9, Canada.
  • McCrea PH; PEI Cancer Treatment Centre, Charlottetown, PE C1A 8T5, Canada.
  • Nair V; Queen Elizabeth II Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
  • Nassabein R; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Nessim C; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 3E4, Canada.
  • Ramjeesingh R; The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Raza M; Queen Elizabeth II Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
  • Saliba W; Dr Everett Chalmers Regional Hospital, Fredericton, NB E3B 5N5, Canada.
  • Samimi S; Cape Breton Cancer Centre, Sydney, NS B1P 1P3, Canada.
  • Singh S; Hôpital Sacré-Coeur de Montréal, Montreal, QC H4J 1C5, Canada.
  • Snow S; Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada.
  • Tehfé M; Queen Elizabeth II Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
  • Thirlwell M; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 3E4, Canada.
  • Valdes M; McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Welch S; Grand River Regional Cancer Centre, Kitchener, ON N2G 1G3, Canada.
  • Vickers M; London Regional Cancer Program, London, ON N6A 5W9, Canada.
Curr Oncol ; 28(3): 1988-2006, 2021 05 26.
Article en En | MEDLINE | ID: mdl-34073199
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19-21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of anal, colorectal, biliary tract, and gastric cancers, including: radiotherapy and systemic therapy for localized and advanced anal cancer; watch and wait strategy for the management of rectal cancer; role of testing for dihydropyrimidine dehydrogenase (DPD) deficiency prior to commencement of fluoropyrimidine therapy; radiotherapy and systemic therapy in the adjuvant and unresectable settings for biliary tract cancer; and radiotherapy and systemic therapy in the perioperative setting for early-stage gastric cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Gastrointestinales Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Curr Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Gastrointestinales Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Curr Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza